- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on ER-positive Breast Cancer
Total 12055 results
-
Washington University School of MedicineNational Cancer Institute (NCI)TerminatedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
Jonsson Comprehensive Cancer CenterBayer; Translational Research in Oncology-U.S. Inc. (TRIO-US)TerminatedStage I Breast Cancer | Stage IV Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Invasive Breast Carcinoma | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | HER2/Neu Negative and other conditionsUnited States
-
Shanghai Proton and Heavy Ion CenterRecruitingTriple Negative Breast Cancer | HER2-positive Breast CancerChina
-
Samsung Medical CenterActive, not recruitingTriple Negative Breast Cancer | HER2-positive Breast CancerKorea, Republic of
-
University of MiamiRecruitingStage IV Breast Cancer | HER2-positive Metastatic Breast CancerUnited States
-
Inova Health Care ServicesCity of Hope Medical CenterRecruitingBreast Cancer | Estrogen Receptor-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)TerminatedStage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Estrogen Receptor-positive Breast Cancer | Progesterone Receptor-positive Breast Cancer | Invasive Ductal Breast CarcinomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnStage I Breast Cancer | Cancer Survivor | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Positive | Progesterone Receptor Positive | Stage... and other conditionsUnited States
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruitingHER2-positive Advanced Breast Cancer
-
Gun Oh ChongNot yet recruitingHormone Receptor-positive Breast Cancer
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityNot yet recruitingHormone Receptor-positive Breast Cancer
-
Peking University People's HospitalRecruitingHER2-positive Early Breast CancerChina
-
University of UtahRecruitingEstrogen Receptor Positive Breast CancerUnited States
-
Hoffmann-La RocheActive, not recruiting
-
Liaoning Tumor Hospital & InstituteCompletedHER2-positive Metastatic Breast CancerChina
-
Memorial Sloan Kettering Cancer CenterHoffmann-La Roche; Genentech, Inc.; Hartford HealthCareActive, not recruitingMetastatic HER2-Positive Breast CancerUnited States
-
Shanghai Institute Of Biological ProductsFudan UniversityCompletedHER2-positive Early Breast CancerChina
-
Vanderbilt-Ingram Cancer CenterActive, not recruitingEstrogen Receptor-positive Breast CancerUnited States
-
Novartis PharmaceuticalsCompletedHormone Receptor Positive Breast CancerUnited States, Argentina, Thailand, Japan, France, Korea, Republic of, Spain, Turkey, Hungary, United Kingdom, Portugal, Brazil, Netherlands
-
Tomsk National Research Medical Center of the Russian...Uppsala UniversityCompletedFemale | HER2-positive Breast CancerRussian Federation
-
Jiangsu HengRui Medicine Co., Ltd.UnknownHER2 Positive Metastatic Breast CancerChina
-
Bio-Thera SolutionsUnknownHER2-positive Advanced Breast CancerChina
-
German Breast GroupBoehringer IngelheimCompleted
-
Zhimin ShaoRoche Pharma AGUnknownHER-2 Positive Breast CancerChina
-
Samsung Medical CenterRecruitingHER2-positive Breast CancerKorea, Republic of
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Latin American Cooperative Oncology GroupRoche Pharma AG; OncoclínicasNot yet recruitingBreast Cancer | HER2-positive Breast CancerBrazil
-
Huashan HospitalRecruitingHER2-positive Breast CancerChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingA Trial of Eribulin in Combination With HP Neoadjuvant Therapy in Patients With for HER2-Positive BCHER2-positive Breast CancerChina
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Cancer Trials IrelandRecruitingHER2-positive Breast CancerIreland
-
Institut de cancérologie Strasbourg EuropeNot yet recruitingHER2-positive Breast Cancer
-
Assiut UniversityNot yet recruiting
-
Shengjing HospitalJiangsu HengRui Medicine Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Kliniken Essen-MitteRecruitingBreast Cancer | Node-positive Breast CancerGermany
-
University Health Network, TorontoRecruitingBreast Cancer | HER2-positive Breast CancerCanada
-
German Breast GroupRoche Pharma AGRecruitingHER2-positive Breast CancerGermany
-
iOMEDICO AGSeagen Inc.RecruitingHER2-positive Breast CancerGermany, Austria
-
Xijing HospitalNot yet recruitingBreast Cancer | HER2-positive Breast Cancer
-
Breast Cancer Trials, Australia and New ZealandRecruitingBreast Cancer | HER2-positive Breast CancerAustralia
-
Fudan UniversityRecruitingHER2-positive Breast CancerChina
-
Genor Biopharma Co., Ltd.RecruitingHER2-positive Breast CancerChina
-
Cancer Institute and Hospital, Chinese Academy...RecruitingHER2-positive Breast CancerChina
-
Parc de Salut MarGEICAMRecruiting
-
University Hospital, Basel, SwitzerlandETOP IBCSG Partners Foundation; Austrian Breast Cancer Study GroupRecruitingNode-positive Breast CancerGreece, Switzerland, Hungary, Austria, Germany, Italy, Lithuania, Argentina, Croatia
-
Centre Jean PerrinRecruitingHER2 Positive Breast CancerFrance
-
Shanghai Henlius BiotechActive, not recruitingBreast Cancer | Breast Neoplasms | HER2-positive Breast CancerChina
-
Daiichi SankyoCompletedHER2-positive Breast CancerSpain, Ireland, Italy
-
University of RochesterSuspendedHER2-positive Breast CancerUnited States
-
Armando GiulianoWithdrawnBreast Cancer | HER2-positive Breast CancerUnited States